Professor of Medicine, University S Ala College of Medicine
Oncology
Dr. Eddie Reed, MD
|
|
Give Review
Eddie Reed, MD is an expert in the field of Oncology. He graduated from Yale University School of Medicine. Yale University School of Medicine is one of the top medical schools in the US. Yale University School of Medicine is ranked 7 in research and 57 in primary care medicine Eddie Reed is a published doctor. He has 14 publications published. The most current publication "Development of an automated ballast water treatment verification system utilizing fluorescein diacetate hydrolysis as a measure of treatment efficacy."
Publications
- Development of an automated ballast water treatment verification system utilizing fluorescein diacetate hydrolysis as a measure of treatment efficacy.
- Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug.
- Validation of a venous thromboembolism risk assessment model in gynecologic oncology.
- GLI1 upregulates C-JUN through a specific 130-kDa isoform.
- Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.
- Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference.
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1, and inhibition of platinum-DNA adduct rep...
- Colorectal Cancer Screening Practices in Alabama: A Survey of Primary Care Physicians.
- Treatment of chemotherapy-induced anemia in ovarian cancer patients: does the use of erythropoiesis-stimulating agents worsen survival?
- CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival.
- Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential ro...
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling.
- Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer.
Schools
Yale University School Of Medicine
Stanford University Hospital
Doctors Specialties
- Internal Medicine
- Oncology
Accepted Insurances
Education
-
Stanford University -
Yale University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Alton B. James, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sobia Ozair, MD |
|
|
Dr. Elizabeth D. Wood, MD |
|
|
Dr. Alfred B. Chance Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan E. Chernick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clare K. Carney, MD |
|
|
Dr. Damian J. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Geoffrey W. Daugherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hung T. Khong, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Meredith C. Roath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica Hals, DO
This Doctor is OpenDoctor Recommended.
|